Pricing Log in Create free account

Aytu BioPharma, Inc. (AYTU) vs Biofrontera Inc. (BFRI)

Aytu BioPharma, Inc. and Biofrontera Inc. are both Drug Manufacturers Specialty & Generic companies. Aytu BioPharma, Inc. is the larger, with a market value of $21.8M against $12.6M — 1.7× the size. Biofrontera Inc. grew revenue faster over the last twelve months: 17.8% against −13.3%. Biofrontera Inc. has the higher net margin (−13.8% vs −24.8%) and the lower return on invested capital (−69.5% vs −20.0%). Across the 18 metrics below, Biofrontera Inc. leads on 11 and Aytu BioPharma, Inc. on 7.

Valuation

Metric AYTU BFRI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.44 0.23 2.11
P/B 0.71 1.78 1.78
Price to free cash flow 7.77 n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.28 0.23 2.73
Earnings yield (67.16%) (54.88%) (4.38%)
Free cash flow yield 12.87% (74.83%) 0.00%

Profitability

Metric AYTU BFRI Drug Manufacturers Specialty & Generic median
Gross margin 63.95% 79.25% 53.94%
Operating margin (14.44%) (14.22%) 0.00%
Net margin (24.76%) (13.78%) 0.00%
Free cash flow margin 5.62% (17.17%) 0.00%
Return on equity (52.55%) (988.35%) (0.40%)
Return on assets (12.44%) (28.80%) (3.32%)
Return on invested capital (19.99%) (69.45%) 0.00%

Growth

Metric AYTU BFRI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) 17.83% 10.01%
EPS growth (last fiscal year) 46.30% 67.70% 49.06%
Revenue growth, 5-year CAGR (2.59%) 17.21% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AYTU BFRI Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 0.78 0.05
Current ratio 1.13 1.18 2.31
Net debt to EBITDA 2.17 0.17 0.97

Dividend

Metric AYTU BFRI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric AYTU BFRI Drug Manufacturers Specialty & Generic median
Market cap 21.84m 12.58m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack